Search
Search Results
##search.searchResults.foundPlural##
-
RECENT ADVANCES IN THE 5Q- SYNDROME
2977PDF: 1899HTML: 3818Pellagatti Fig 1: 249Pellagatti Fig. 2: 242 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3357PDF: 974HTML: 3312 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2547PDF: 1232HTML: 1073 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3874PDF: 1652HTML: 866Figures . Eliassian: 256 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2677PDF: 846HTML: 5378 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1539HTML: 658PDF: 885 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2607PDF: 1753HTML: 593 -
Pseudo-differentiation syndrome
1449PDF: 699HTML: 10882Figure 1: peripheral blood showing myeloblasts with auer rods: 141Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 126Figure 3: CXR showing pulmonary infiltartes with consolidation: 151Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 133Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 133 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2307PDF: 1846HTML: 847 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
4074PDF: 785HTML: 1889 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4923PDF: 1908HTML: 2193 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2091PDF: 1641HTML: 805 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3925PDF: 1729HTML: 11847Figures Haase: 239 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3888PDF: 1544HTML: 349 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1964PDF: 1045HTML: 248 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1854PDF: 975HTML: 1199Untitled: 186Untitled: 205Untitled: 193Untitled: 188 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4598PDF: 3776HTML: 375 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1853PDF: 913HTML: 460Fig1: 261Fig.2: 276Fig. 3: 218Fig. 5: 228Fig. 4: 255 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2988PDF: 1057HTML: 5644 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1291PDF: 630HTML: 2911ATRA induced Reactive Hemophagocytosis: A Case Report: 222 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1941PDF: 856HTML: 10358Figures 1,2,3: 226 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1543PDF: 951Suppl. Files: 475HTML: 297 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1178PDF: 866HTML: 271 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7888PDF: 2494HTML: 2120Table 1.: 251Table 2.: 261Table 3.: 242Table 4.: 238 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1359PDF: 914HTML: 1201Coverletter: 238 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3611PDF: 922HTML: 1691figure 1: 191Untitled: 216 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13355PDF: 1019HTML: 7318 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1312PDF: 549HTML: 23179 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3051PDF: 1066HTML: 1463 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1835PDF: 587HTML: 16996Figure 4: 194Figure 3: 164Figure 2: 170Figure 1: 206 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1502PDF: 969HTML: 255 -
-
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1170PDF: 1222Suppl. Files: 589HTML: 99 -
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2386PDF: 1367HTML: 17209Bassan Fig.1: 164Bassan Fig.2: 268Bassan Fig.4: 157Fig.3: 228







